The Rebirth of a Phoenix: Ovarian Cancers Are Addicted to ErbB-3

Gordon B. Mills, Yosef Yarden

Research output: Contribution to journalShort surveypeer-review

17 Scopus citations

Abstract

Several cancer drugs intercept the ErbB family receptors EGFR (ErbB-1) and HER2 (ErbB-2). However, the therapeutic value of targeting ErbB-3 has been less clear. A report in this issue of Cancer Cell by Sheng et al. renews hopes that intercepting ErbB-3-mediated autocrine loops bears potential for treatment of ovarian cancer.

Original languageEnglish (US)
Pages (from-to)217-218
Number of pages2
JournalCancer Cell
Volume17
Issue number3
DOIs
StatePublished - Mar 16 2010
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cell Biology
  • Cancer Research

Fingerprint

Dive into the research topics of 'The Rebirth of a Phoenix: Ovarian Cancers Are Addicted to ErbB-3'. Together they form a unique fingerprint.

Cite this